A 42-year-old woman from Tamil Nadu presents with sudden onset of facial swelling, pain in her hands and feet, and fever for 5 days. She was diagnosed with leprosy 6 months ago and completed 6 months of multidrug therapy (MDT) 2 weeks ago. On examination, she has tender nodules on her earlobes and shins, and her previously healed skin lesions are now inflamed. Slit-skin smear shows numerous acid-fast bacilli. What is the most likely diagnosis?

Explanation

## Clinical Analysis This patient presents with **Erythema Nodosum Leprosum (ENL)**, a Type 3 (immune complex-mediated) hypersensitivity reaction. ### Distinguishing Features of ENL vs. Type 1 Reversal Reaction | Feature | ENL (Type 3) | Type 1 Reversal Reaction | |---------|--------------|------------------------| | **Timing** | During treatment or within 2 years post-treatment | During treatment or shortly after | | **Associated leprosy type** | Lepromatous (LL) and borderline lepromatous (BL) | Borderline forms (BT, BL) | | **Lesion characteristics** | Tender nodules, erythema nodosum-like | Inflammation of existing lesions | | **Systemic features** | Fever, arthralgia, neuritis, iritis, hepatosplenomegaly | Neuritis, sensory loss changes | | **Bacilli load** | Numerous (patient still harbors bacilli) | Variable | | **Immune mechanism** | Immune complex deposition (Type III) | Cell-mediated immunity shift (Type IV) | | **Treatment** | Corticosteroids, thalidomide | Corticosteroids alone | **Key Point:** ENL occurs in **lepromatous-spectrum patients** (LL, BL) and is triggered by **immune reconstitution**—either during treatment as immunity improves or post-treatment as residual antigen stimulates antibody responses. ### Why This Case Is ENL 1. **Timing: 2 weeks post-MDT completion** → Classic for ENL (can occur up to 2 years after treatment) 2. **Tender nodules on earlobes and shins** → Erythema nodosum-like lesions, hallmark of ENL 3. **Systemic symptoms: fever, arthralgia** → ENL is a systemic reaction 4. **Numerous acid-fast bacilli on smear** → Indicates lepromatous-spectrum disease (LL or BL) 5. **Inflamed previously healed lesions** → Suggests immune complex deposition in old lesion sites **Clinical Pearl:** ENL is an **immune complex disease** that paradoxically indicates **improving immunity**. It is more common in patients with high bacillary loads (LL, BL) and occurs as the immune system begins to recognize and respond to mycobacterial antigens. **High-Yield:** **Thalidomide** is the drug of choice for ENL (especially in severe cases), while **corticosteroids** are first-line for mild-to-moderate ENL and are also used for Type 1 reversal reactions. **Mnemonic: ENL-FAIN** — **F**ever, **A**rthralgia, **I**ritis, **N**euritis (systemic manifestations of ENL). [cite:Park 26e Ch 11; Harrison 21e Ch 195]